Analysts Offer Insights on Healthcare Companies: Palatin Technologies (PTN), Prestige Consumer Healthcare (PBH) and CervoMed (CRVO)
Palatin Techs Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Palatin Techs, Maintains $17 Price Target
Analysts Are Bullish on These Healthcare Stocks: AEON Biopharma (AEON), Palatin Technologies (PTN)
HC Wainwright & Co. Reiterates Buy on Palatin Techs, Maintains $17 Price Target
Palatin Techs Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST) and Palatin Technologies (PTN)
Palatin Techs Analyst Ratings
Buy Rating Endorsed for Palatin Technologies Amidst Promising Obesity Treatment Advancements
Buy Rating Affirmed for Palatin Technologies Following Successful Phase 3 Trial of PL9643 for Dry Eye Disease
Maintained Buy Rating on Palatin Technologies Amid Promising Clinical Results and Future Prospects
Analysts Offer Insights on Healthcare Companies: Palatin Technologies (PTN) and Opko Health (OPK)
Buy Rating Affirmed on Palatin Technologies for Promising Pipeline and Strategic Market Positioning
Palatin Techs Analyst Ratings
Optimistic Buy Rating for Palatin Technologies Backed by Strong Clinical Pipeline and Strategic Initiatives
Optimistic Outlook for Palatin Technologies: A Comprehensive Buy Rating Based on Strong Clinical Pipeline and Upcoming Milestones
Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA), Henry Schein (HSIC) and Palatin Technologies (PTN)
Analysts Are Bullish on Top Healthcare Stocks: Bioventus (BVS), Palatin Technologies (PTN)
Analysts Offer Insights on Healthcare Companies: Illumina (ILMN), Palatin Technologies (PTN) and Medtronic (MDT)
Analysts Offer Insights on Healthcare Companies: Urogen Pharma (URGN), Palatin Technologies (PTN) and ProKidney (PROK)
No Data